WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Shepherd Center
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
HealthITAnalytics: | February 13, 2020
The National Human Genome Research Institute (NHGRI) has announced that it will establish a new precision medicine and genomics program within its Division of Intramural Research. The new program will leverage innovative genomics and informatics tools to improve the diagnosis, treatment, and prevention of disease, as well as develop the next generation of healthcare. Over the last decade, advancements in genomic technologies, computation, and data science have led to the growth of large genomic ...
Healthcare Analytics
Business Wire | October 04, 2023
AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, today announced the completion of its acquisition of Avanos Medical, Inc.’s (NYSE: AVNS) (“Avanos”) respiratory health business, including the BALLARD*, MICROCUFF* and endOclear® product lines. The acquisition adds ...
Health Technology, Digital Healthcare
Business Wire | October 16, 2023
HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer, and enterprise markets, announced that its Digital Transformation Solutions business unit has launched the groundbreaking Healthcare Private Language Model (LLM), known as HealthGPT. HealthGPT represents a leap in healthcare solutions by leveraging generative AI to empower hea...
HITInfrastructure | March 26, 2020
A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...
Article
Healthtech Security
infographic
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE